1.Balloon Catheter Dilation of Anastomotic Esophageal Strictures in Infant
Guopin LI ; Qinghua YAO ;
Journal of Interventional Radiology 1994;0(02):-
Purpose:Balloon catheter dilation was performed in 4 young infants with anas- tomotic esophageal strictures.To discuss the method of balloon dilation and evaluation of successful. Materials and Methods:The 4 cases had an anastomotic stricture after surgical correction of esophageal atresia.Their age range was 2 to 15 months.Each case had a barium esophagram before balloon dilation.The diameter of esophageal stricture ranged from 3 to 6mm.The balloon size from 3 to 15mm in diameter.Results:All of the 4 cases complete resolution of the strictures was achieved after 1 to 4 dilations.There was no esophageal perforation.Conclution:Balloon catheter dilation presented in the paper is a simple,safe and reliable one for the treatment of anastomotic esophageal stricture in young infant as first choice treatment.
2.Clinic Observation of Tiepi Fengdou Granule as Adjuvant Treatment in Cancer Patients During Chemotherapy
Journal of Zhejiang Chinese Medical University 2006;0(04):-
[Objective] To evaluate the effect of Tiepi Fengdou Granule(TFG) as adjuvant treatment in cancer patients during chemotherapy.[Methods] Twenty patients were treated with TFG,and then we added up integral calculus of Yin Deficiency symptoms,tested blood routine,hepatic and renal function and subgroup of T-cell and NK cell.[Results] The Yin Deficiency symptoms of 7 cases(35%) were improved significantly,and 13 cases were partly improved(65%).Each integral calculus of Yin Deficiency symptoms was descended.The tested blood routine,hepatic function and subgroup of T-cell and NK cell were changed significantly.[Conclusions] TFG could control the symptoms of Yin Deficiency and improve immune function for cancer chemotherapy patients.
3.Inhibitory effect of L-arginine on cardiac allograft vasculopathy in a rat cardiac allograft model
Qinghua ZHANG ; Zhifa YAO ; Wangfu ZANG
Chinese Journal of Organ Transplantation 1996;0(02):-
Objective To explore the inhibitory effect of L-arginine on cardiac allograft vasculopathy (CAV) and its possible mechanisms.Methods The rat cardiac allograft model was used. In the control group (n=26), L-arginine was not administered after heterotopic cardiac transplantation, and the other 21 rats (experimental group) received administration of L-arginine ( 800?mg/kg every day, in drinking water) after heart transplantation. CAV score was evaluated and plasma nitric oxide (NO) was measured at 2 and 3 months after transplantation. Results Graft survival rate 2 months after transplantation was significantly (P
4.Experimental Study of the Qi Deficiency and Blood Stasis Syndrome Related to Artificial Hematogenous Metastasis of Conlon Cancer in Balb/c Rats
Qinghua YAO ; Ting LOU ; Yong GUO
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(07):-
Objective :To Study the Relationship between the Qi Deficiency and Blood Stasis Syndrome and artificial hematogenous metastasis of colon cancer by establishing a compound model of Qi Deficiency and Blood Stasis Syndrome and artificial hematogenous metastasis of colon cancer. Methods:Thirty six eight-weeks old female Balb/c rats were divided into six groups randomly:control group ,stasis group,tumor groupA、B ,stasis and tumor groupA、B. We observed the survival time of tumor groupB and stasis and tumor groupB. At the 28th day,after killing the mice of the other groups,we detected the whole blood viscosity and the amounts of metastasis tubercle on lung. Results:The weight of the stasis group increase more slowly than control group(P
5.Portal pressure gradient changes predict recurrent bleeding after selective devascularization
Qinghua ZHANG ; Wanneng PAN ; Gang XU ; Xuefeng ZHANG ; Guanyu YAO
Chinese Journal of General Surgery 2011;26(2):116-119
Objective To investigate the relationship between the changes of portal pressure gradient after selective devascularization with postoperative complications and recurrent bleeding of gastroesophageal varix in patients of portal hypertension. Methods The clinical data of 135 cases of portal hypertension undergoing selective devascularization was collected. Portal pressure gradient was measured before splenectomy and after selective devascularization, and was analyzed against postoperative complications and recurrent bleeding. Results In this study, 135 patients of portal hypertension underwent selective devascularization, two cases died during perioperative period ( 1.5% ). Postoperatively patients were divided into three groups based on PPG < 12 mm Hg after selective devascularization (62 cases), HVPG ≥ 12 mm Hg but a more than 20% of decrease off the pre-splenectomy baseline (41 cases) and HVPG ≥12 mm Hg with less than 20% of decrease from the baseline (32 cases). The postoperative complications between the three groups were of no significant difference ( P > 0. 05 ). The 1,2,3 year cumulative rate of no variceal rebleeding of the three groups were 100% vs. 100% vs. 95%; 100%vs. 97% vs. 90%; and 100% vs. 93% vs. 87% (x2 =6. 859, P = 0. 032). COX regression analysis indicated portal vein pressure gradient was an independent prognostic factor of variceal bleeding recurrence (P=0.002). 1,2,3 year cumulative survival rates of the three groups were 100% vs. 100% vs. 94%; 98% vs. 95% vs. 92%; 97% vs. 93% vs. 88%, there were no significant difference among the three groups ( x2 = 2. 917, P = 0. 233 ). Conclusions The decrease in the PPG after selective devascularization is a predictor for the risk of rebleeding but not for survival after selective devascularization.
6.Effects of Huoxue Tongmai Lishui method on fundus fluorescein angiography of non-ischemic retinal vein occlusion: a randomized controlled trial.
Qinghua PENG ; Xiaolei YAO ; Zhicheng ZENG ; Ruibing SU ; Yanping WEI
Journal of Integrative Medicine 2009;7(11):1035-41
Huoxue Tongmai Lishui method, a traditional Chinese medicine treatment for eliminating water, activating and promoting blood circulation, could inhibit fundus hemorrhage on experimental retinal vein occlusion (RVO) with high obvious effective rate, and improve symptoms in traditional Chinese medicine. The action mechanism may be related to reducing plasma viscosity and non-perfusion area, and the formation of collateral circulation.
7.The relationship between coagulation-coagulation suppression system disorders and portal vein thrombosis in portal hypertensive patients
Qinghua ZHANG ; Ke LU ; Gang XU ; Guanyu YAO ; Wanneng PAN
Chinese Journal of General Surgery 2013;28(10):774-777
Objective To explore the correlation between coagulation and coagulation suppresion system disorders of portal vein thrombosis in patients of portal hypertension undergoing splenectomy.Methods Clinical data of 33 patients with postoperative portal vein thrombosis were enrolled.The clotting and coagulation inhibitor in portal vein blood and peripheral blood was detected and analyzed.Results The Hb,APTT,FIB,factor Ⅶ,protein C,AT-Ⅲ,CD62P of portal vein blood and peripheral blood before the surgery and on postoperative day 1,day 7,day 14 were no significant difference (P > 0.05).The WBC,PLT,PT,D-Dimer of in portal vein blood before surgery were (2.9 ± 1.4) × 109/L,(37.5 ± 20.7) × 109/L,(16.1 ± 2.9) seconds,(0.7 ± 0.3) μg/ml,which were significantly different from those on postop day 1 (13.7 ±4.4) × 109/L,(86.3 ±34.6) × 109/L,(6.9 ±5.7) seconds,(16.1 ±2.9) μg/ml; day 7 (10.7 ±4.3) × 109/L,(312.4 ±137.2) × 109/L,(14.4 ±2.9) seconds,(7.6 ±4.4) μg/ml and day 14 (7.7 ± 3.3) × 109/L,(486.3 ± 216.7) × 109/L,(14.4 ± 2.9) seconds,(5.5 ± 4.4) μg/ml (P < 0.05).WBC,PLT,PT,D-Dimer in preop peripheral blood were (2.4 ±0.8) × 109/L,(44.4 ± 25.8) × 109/L,(16.3 ± 3.0) seconds,(0.6 ± 0.4) μg/ml,which were significantly different from those on postop day 1 (13.7 ± 5.7) × 109/L,(75.1 ± 29.3) × 109/L,(13.7 ± 2.6) seconds,(6.8 ± 5.3) μg/ml; day 7 (10.6 ± 4.8) × 109/L,(337.9 ± 141.3) × 109/L,(14.0 ± 2.1) seconds,(7.6 ± 5.5) μg/ml and day 14 (7.8 ±3.9) × 109/L,(504.9 ±237.4) × 109/L,(14.0 ±2.1) seconds,(5.4 ±4.9) μg/ml postoperative (P < 0.05).Conclusions The cause of postsplenectomy portal vein thrombosis is multifactorial.The dysfunction of coagulation-coagulation suppression system was just one of the conditions conducive to portal vein thrombosis after splenectomy.
9.Construction and expression of the fusional genes Hsp65-Esat6 expressing plasmid of mycobacterium tuberculosis
Junwu LI ; Zeqi HUANG ; Cuichan YAO ; Shuguang ZHOU ; Xiaodong LI ; Dong SONG ; Qinghua HUANG
Chinese Journal of Tissue Engineering Research 2007;11(29):5836-5839
BACKGROUND:There is a linker between Hsp65 and Esat6 coding a segment of water repellent polypeptide.It is very gentle and easy to be folded,which is profitable to translate the keno-folding correctly between the two proteins and to make the space structure of fusional proteins consistent with those two native ones.Then,a correct structure is formed and the immunogenicity of the fusional proteins is improved.OBJECTIVE:This study was to clone the fusional genes Hsp65-Esat6 from mycobacterium tuberculosis(MTB)H37Rv, then to construct into a eukaryotic expressing vector which contains an enhanced green fluorescent protein(EGFP) reporter gene,and finally to identify the expression of Hsp65 protein and Esat6 protein by IHC methods.DESIGN:Single sample experiment.SETTING:Department of Microbiology & Immunology,Medical College of Jinan University.MATERIALS:Plasmid pVAE was donated by Professor Cao from South China University of Technology.MTB H37Rv,E.coil DH5 α,expressing plasmid pEGFP-C1 and Hela cells were donated by Doctor Hu Ping.METHODS:The experiment was conducted at the Department of Microbiology & Immunology and the Medical Experimental Center of Jinan University between September 2005 and June 2006.The whole-genome was extracted from MTB H37Rv by molecular cloning technique,and used it as template to amplify Hsp65 (no terminator) gene by polyrnerase chain reaction (PCR),to recombine it with pEGFP-C1 vector after purification to construct pEGHsp65(no terminator)recombination vector.pVAE vector was used as template to amplify Linker-Esat6 gene(with terminator)by PCR, and then to recombine it with pEGHSP65(no terminator)to construct an eukaryotic expressing vector pEGHsp65-Esat6 with the fusional genes Hsp65-Esat6 inside.Finally,genes Hsp65-Esat was checked by molecule biology methods such as PCR, restriction endonuclease and DNA sequencing.Hela cells were transfected with pEGHsp65-Esat6 and the expression of EGFP and the efficiency of transfection were observed.The expressions of Hsp65 protein and Esat6 protein were detected by IHC methods.MAIN OUTCOME MEASURES:①The size of pEGHsp65-Esat6.②The DNA sequencing result of the pEGFP-C1.③The expression of EGFP in the transfected Hela cells.④The IHC results of Hsp65 protein and Esat6 protein in Hela cells.RESULTS:①The size of pEGFP-C1 was 4.7 kb,that of pEGHsp65 was 6.4 kb,and that of pEGHsp65-Esat6 was 6.7 kb.There were differences between their speeds In agarose electrophoresis.②The results showed that it was the same as reported Hsp65 sequence and Esat6 sequence of MTB H37Rv.③After transfecting pEGHsp65-Esat6 for 24 hours,EGFP was found in 30% of Hela through Laser scanning confocal microscope. But there was no EGFP in non-transfected Hela.④Hsp65 protein and Esat6 protein with biological activities were detected in transfected Hela cells by IHC methods.CONCLUSION: Using Hsp65 and Esat6 as immunogens,we have successfully cloned and constructed a eukaryotic expressing vector which contain fusionaI genes Hsp65-Esat6 of MTB H37Rv and EGFP.
10.Different pancreatic islet β cell function index for the evaluation of glucose metabolism in type 2 diabetes
Huanhuan XIN ; Guangxia XI ; Yao CHEN ; Yuanyuan ZHAO ; Qinghua GUO ; Yunhong JIAO ; Xueli ZHANG
Chinese Journal of Postgraduates of Medicine 2012;35(4):13-15
Objective To assess the role of the different pancreatic islet β cell function index in the evaluation of glucose metabolism in different duration of type 2 diabetes mellitus (T2DM).Methods Normal glucose tolerance subjects without diabetes family history (NC group,48 cases) and T2DM patients (182 cases) were enrolled.The T2DM patients were divided into three groups:less than 5 years group (DM <5 group,74 cases),5-10 years group (DM5-10 group,51 cases) and more than 10 years group ( DM >10 group,57 cases).Oral glucose tolerance test (OGTT) and insulin release test were taken in all groups.Insulin resistance index (HOMA-IR) and whole body insulin sensitivity index [ISI(Matsuda)] were used to estimate insulin sensitivity,and early insulin secretion index ( △ I30/ △ G30) and glucose disposition index (DI) were used to evaluate the function of pancreatic islet β cell.Results HOMA-IR was increased and ISI (Matsuda) was decreased in DM <5 group,DM5-10 group and DM >10 group compared with those in NC group [HOMA-IR:8.78 ± 7.12,8.08 ± 3.67,7.84 ± 5.08 vs.4.76 ± 3.43;ISI(Matsuda):46.78 ± 29.00,36.71 ± 16.67,38.86 ±21.72 vs.61.13 ± 32.08,P < 0.05],however,there was no significant difference among DM <5 group,DM5-10 group and DM >10 group.△ I30/ △ G30 and DI were decreased in DM <5 group,DM5-10 group and DM >10 group compared with those in NC group [ △ I30 △ G30:( 68.41 ± 361.52 ),(4.31 ± 3.42 ),(7.70 ± 5.78 ) mU/mmol vs.(92.65 ± 309.29) mU/mmol;DI:0.0421 ± 0.0123,0.0412 ± 0.0123,0.0363 ± 0.0116 vs.0.1151 ± 0.0236,P < 0.05 ],and there was no significant difference in △ I30 / △ G30 among DM <5 group,DM5-10 group and DM >10 group,however,DI was decreased in DM>10 group compared with that in DM<5 group and DM5-10 group (P<0.05).ConclusionsHOMA-IR,ISI (Matsuda),△I30/△G30 are not sensitive to evaluate the insulin resistance of different duration.DI can reflect the glucose utilization of pancreatic islet β cell earlier and the ability to regulate blood sugar steady state changes.